Brief: Mendus AB Announces Positive 2-Year Follow-Up Data From Alison Trial

Mendus AB (publ)

27/11/2025 07:03

Nov 27 (Reuters) - Mendus AB (publ) IMMUN.ST:

ANNOUNCES POSITIVE 2-YEAR FOLLOW-UP DATA FROM ALISON TRIAL

NO SERIOUS SIDE EFFECTS CONFIRM STRONG SAFETY PROFILE

IMPROVED IMMUNE RESPONSES LINKED TO BETTER SURVIVAL

Source text: ID:nMFN20JJkL

Further company coverage: IMMUN.ST

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))